- call +1-201-465-4211
- email sales@mrinsights.biz
Donepezil is a medication used in the palliative treatment of Alzheimer's disease. Donepezil is used to improve cognition and behavior of people with Alzheimer's, but does not slow the progression of or cure the disease.
Common side effects include loss of appetite, gastrointestinal upset, diarrhea, difficulty sleeping, vomiting, or muscle cramping.
Scope of the Report:
The classification of Donepezil includes 5mg, 10mg and 23mg, and the proportion of 10mg in 2017 is about 48%.
North America is the largest consumption region of Donepezil, with a sales market share nearly 37% in 2017. Europe is the second largest consumption region of Donepezil, enjoying Sales market share nearly 29% in 2017.
Donepezil was developed by Eisai and Pfizer and is sold as a generic by multiple suppliers. Donepezil acts as a centrally acting reversible acetylcholinesterase inhibitor.
The worldwide market for Donepezil is expected to grow at a CAGR of roughly -1.6% over the next five years, will reach 830 million US$ in 2024, from 920 million US$ in 2019, according to a new study.
This report focuses on the Donepezil in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Eisai
Pfizer
Teva
Sandoz
Apotex
Dr Reddy's Laboratories
Sun Pharmaceutical
Hansoh Pharma
Cipla
ARK PHA.LTD
Jishengtang Pharma
Luoxin
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
5mg
10mg
23mg
Market Segment by Applications, can be divided into
Hospitals
Clinics
Drugstore
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Donepezil product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Donepezil, with price, sales, revenue and global market share of Donepezil in 2017 and 2018.
Chapter 3, the Donepezil competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Donepezil breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Donepezil market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Donepezil sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Donepezil Introduction
1.2 Market Analysis by Type
1.2.1 5mg
1.2.2 10mg
1.2.3 23mg
1.3 Market Analysis by Applications
1.3.1 Hospitals
1.3.2 Clinics
1.3.3 Drugstore
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Eisai
2.1.1 Business Overview
2.1.2 Donepezil Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Eisai Donepezil Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Pfizer
2.2.1 Business Overview
2.2.2 Donepezil Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Pfizer Donepezil Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 Teva
2.3.1 Business Overview
2.3.2 Donepezil Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Teva Donepezil Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Sandoz
2.4.1 Business Overview
2.4.2 Donepezil Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Sandoz Donepezil Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 Apotex
2.5.1 Business Overview
2.5.2 Donepezil Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Apotex Donepezil Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 Dr Reddy's Laboratories
2.6.1 Business Overview
2.6.2 Donepezil Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Dr Reddy's Laboratories Donepezil Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 Sun Pharmaceutical
2.7.1 Business Overview
2.7.2 Donepezil Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Sun Pharmaceutical Donepezil Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.8 Hansoh Pharma
2.8.1 Business Overview
2.8.2 Donepezil Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Hansoh Pharma Donepezil Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.9 Cipla
2.9.1 Business Overview
2.9.2 Donepezil Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Cipla Donepezil Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.10 ARK PHA.LTD
2.10.1 Business Overview
2.10.2 Donepezil Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 ARK PHA.LTD Donepezil Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.11 Jishengtang Pharma
2.11.1 Business Overview
2.11.2 Donepezil Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Jishengtang Pharma Donepezil Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.12 Luoxin
2.12.1 Business Overview
2.12.2 Donepezil Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Luoxin Donepezil Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Donepezil Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Donepezil Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Donepezil Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Donepezil Manufacturer Market Share in 2018
3.3.2 Top 6 Donepezil Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Donepezil Market Analysis by Regions
4.1 Global Donepezil Sales, Revenue and Market Share by Regions
4.1.1 Global Donepezil Sales and Market Share by Regions (2014-2019)
4.1.2 Global Donepezil Revenue and Market Share by Regions (2014-2019)
4.2 North America Donepezil Sales and Growth Rate (2014-2019)
4.3 Europe Donepezil Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Donepezil Sales and Growth Rate (2014-2019)
4.5 South America Donepezil Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Donepezil Sales and Growth Rate (2014-2019)
5 North America Donepezil by Country
5.1 North America Donepezil Sales, Revenue and Market Share by Country
5.1.1 North America Donepezil Sales and Market Share by Country (2014-2019)
5.1.2 North America Donepezil Revenue and Market Share by Country (2014-2019)
5.2 United States Donepezil Sales and Growth Rate (2014-2019)
5.3 Canada Donepezil Sales and Growth Rate (2014-2019)
5.4 Mexico Donepezil Sales and Growth Rate (2014-2019)
6 Europe Donepezil by Country
6.1 Europe Donepezil Sales, Revenue and Market Share by Country
6.1.1 Europe Donepezil Sales and Market Share by Country (2014-2019)
6.1.2 Europe Donepezil Revenue and Market Share by Country (2014-2019)
6.2 Germany Donepezil Sales and Growth Rate (2014-2019)
6.3 UK Donepezil Sales and Growth Rate (2014-2019)
6.4 France Donepezil Sales and Growth Rate (2014-2019)
6.5 Russia Donepezil Sales and Growth Rate (2014-2019)
6.6 Italy Donepezil Sales and Growth Rate (2014-2019)
7 Asia-Pacific Donepezil by Country
7.1 Asia-Pacific Donepezil Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Donepezil Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Donepezil Revenue and Market Share by Country (2014-2019)
7.2 China Donepezil Sales and Growth Rate (2014-2019)
7.3 Japan Donepezil Sales and Growth Rate (2014-2019)
7.4 Korea Donepezil Sales and Growth Rate (2014-2019)
7.5 India Donepezil Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Donepezil Sales and Growth Rate (2014-2019)
8 South America Donepezil by Country
8.1 South America Donepezil Sales, Revenue and Market Share by Country
8.1.1 South America Donepezil Sales and Market Share by Country (2014-2019)
8.1.2 South America Donepezil Revenue and Market Share by Country (2014-2019)
8.2 Brazil Donepezil Sales and Growth Rate (2014-2019)
8.3 Argentina Donepezil Sales and Growth Rate (2014-2019)
8.4 Colombia Donepezil Sales and Growth Rate (2014-2019)
9 Middle East and Africa Donepezil by Countries
9.1 Middle East and Africa Donepezil Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Donepezil Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Donepezil Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Donepezil Sales and Growth Rate (2014-2019)
9.3 Turkey Donepezil Sales and Growth Rate (2014-2019)
9.4 Egypt Donepezil Sales and Growth Rate (2014-2019)
9.5 Nigeria Donepezil Sales and Growth Rate (2014-2019)
9.6 South Africa Donepezil Sales and Growth Rate (2014-2019)
10 Global Donepezil Market Segment by Type
10.1 Global Donepezil Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Donepezil Sales and Market Share by Type (2014-2019)
10.1.2 Global Donepezil Revenue and Market Share by Type (2014-2019)
10.2 5mg Sales Growth and Price
10.2.1 Global 5mg Sales Growth (2014-2019)
10.2.2 Global 5mg Price (2014-2019)
10.3 10mg Sales Growth and Price
10.3.1 Global 10mg Sales Growth (2014-2019)
10.3.2 Global 10mg Price (2014-2019)
10.4 23mg Sales Growth and Price
10.4.1 Global 23mg Sales Growth (2014-2019)
10.4.2 Global 23mg Price (2014-2019)
11 Global Donepezil Market Segment by Application
11.1 Global Donepezil Sales Market Share by Application (2014-2019)
11.2 Hospitals Sales Growth (2014-2019)
11.3 Clinics Sales Growth (2014-2019)
11.4 Drugstore Sales Growth (2014-2019)
12 Donepezil Market Forecast (2019-2024)
12.1 Global Donepezil Sales, Revenue and Growth Rate (2019-2024)
12.2 Donepezil Market Forecast by Regions (2019-2024)
12.2.1 North America Donepezil Market Forecast (2019-2024)
12.2.2 Europe Donepezil Market Forecast (2019-2024)
12.2.3 Asia-Pacific Donepezil Market Forecast (2019-2024)
12.2.4 South America Donepezil Market Forecast (2019-2024)
12.2.5 Middle East and Africa Donepezil Market Forecast (2019-2024)
12.3 Donepezil Market Forecast by Type (2019-2024)
12.3.1 Global Donepezil Sales Forecast by Type (2019-2024)
12.3.2 Global Donepezil Market Share Forecast by Type (2019-2024)
12.4 Donepezil Market Forecast by Application (2019-2024)
12.4.1 Global Donepezil Sales Forecast by Application (2019-2024)
12.4.2 Global Donepezil Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Donepezil Picture
Table Product Specifications of Donepezil
Figure Global Sales Market Share of Donepezil by Types in 2018
Table Donepezil Types for Maj
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
